Kewaunee Scientific (NASDAQ:KEQU – Get Free Report) is one of 511 public companies in the “Healthcare Equipment & Supplies” industry, but how does it compare to its competitors? We will compare Kewaunee Scientific to similar businesses based on the strength of its dividends, valuation, profitability, institutional ownership, earnings, analyst recommendations and risk.
Analyst Recommendations
This is a breakdown of current ratings for Kewaunee Scientific and its competitors, as provided by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Kewaunee Scientific | 0 | 1 | 0 | 0 | 2.00 |
| Kewaunee Scientific Competitors | 4291 | 10580 | 18364 | 831 | 2.46 |
As a group, “Healthcare Equipment & Supplies” companies have a potential upside of 21.65%. Given Kewaunee Scientific’s competitors stronger consensus rating and higher probable upside, analysts clearly believe Kewaunee Scientific has less favorable growth aspects than its competitors.
Institutional & Insider Ownership
32.7% of Kewaunee Scientific shares are owned by institutional investors. Comparatively, 40.5% of shares of all “Healthcare Equipment & Supplies” companies are owned by institutional investors. 14.1% of Kewaunee Scientific shares are owned by company insiders. Comparatively, 14.9% of shares of all “Healthcare Equipment & Supplies” companies are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.
Volatility and Risk
Kewaunee Scientific has a beta of 0.82, indicating that its share price is 18% less volatile than the S&P 500. Comparatively, Kewaunee Scientific’s competitors have a beta of 2.57, indicating that their average share price is 157% more volatile than the S&P 500.
Valuation & Earnings
This table compares Kewaunee Scientific and its competitors revenue, earnings per share and valuation.
| Gross Revenue | Net Income | Price/Earnings Ratio | |
| Kewaunee Scientific | $277.21 million | $9.62 million | 13.02 |
| Kewaunee Scientific Competitors | $1.90 billion | $135.83 million | 5.97 |
Kewaunee Scientific’s competitors have higher revenue and earnings than Kewaunee Scientific. Kewaunee Scientific is trading at a higher price-to-earnings ratio than its competitors, indicating that it is currently more expensive than other companies in its industry.
Profitability
This table compares Kewaunee Scientific and its competitors’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Kewaunee Scientific | 2.97% | 11.61% | 4.82% |
| Kewaunee Scientific Competitors | -304.20% | -315.07% | -22.11% |
Dividends
Kewaunee Scientific pays an annual dividend of $0.76 per share and has a dividend yield of 2.1%. Kewaunee Scientific pays out 27.5% of its earnings in the form of a dividend. As a group, “Healthcare Equipment & Supplies” companies pay a dividend yield of 2.1% and pay out 47.8% of their earnings in the form of a dividend.
Summary
Kewaunee Scientific competitors beat Kewaunee Scientific on 10 of the 15 factors compared.
About Kewaunee Scientific
Kewaunee Scientific Corporation (NASDAQ: KEQU) designs, manufactures and installs laboratory, healthcare and technical furniture and related infrastructure. Its product portfolio includes laboratory casework, workstations, fume hoods, sinks, storage systems, technical furniture and other specialized equipment used in research and testing environments. The company serves customers in markets including education, healthcare, pharmaceutical and biotechnology research, industrial manufacturing, government and other scientific applications.
Receive News & Ratings for Kewaunee Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kewaunee Scientific and related companies with MarketBeat.com's FREE daily email newsletter.
